CIK 0002040475 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Drugs Made In America Acquisition II Corp.
Sign in to watch- Ticker
- DMII
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 954-870-3104
- Business address
- 420 LEXINGTON AVENUE, SUITE 1402, NEW YORK, NY, 10170
Securities
- DMII Ordinary Shares Nasdaq
- DMIIR Right Nasdaq
- DMIIU Unit Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-26 | Do Catherine Director | Other acquisition | +100,000 | 100,000 | ||
| 2025-09-26 | Shulgan Myron W. Director | Other acquisition | +100,000 | 100,000 | ||
| 2025-09-26 | Worman Glenn C. CFO | Other acquisition | +100,000 | 100,000 | ||
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Purchase | +700,000 | 15,075,000 | ||
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Other disposition | −400,000 | 14,675,000 | ||
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Sale | −7,966,667 | 6,708,333 | ||
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Purchase · Rights to receive ordinary shares | +700,000 | 700,000 | ||
| 2025-09-26 | Drugs Made In America Acquisition II LLC 10% owner | Purchase | +700,000 | 15,075,000 | ||
| 2025-09-26 | Drugs Made In America Acquisition II LLC 10% owner | Other disposition | −400,000 | 14,675,000 | ||
| 2025-09-26 | Drugs Made In America Acquisition II LLC 10% owner | Sale | −7,966,667 | 6,708,333 | ||
| 2025-09-26 | Drugs Made In America Acquisition II LLC 10% owner | Purchase · Rights to receive ordinary shares | +700,000 | 700,000 | ||
| 2025-09-26 | Prasad Sridhar G. Director | Other acquisition | +100,000 | 100,000 |
Page 1 of 1 · 12 trades